Skip to content

Clinical trials

COVID-19 trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: COVID-19 Country / region: Brazil Clear all

306 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20151
20181
2020146
2021100
202238
20239
20248
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed161
Unknown status81
Terminated44
Recruiting9
Withdrawn4
Suspended4
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
D'Or Institute for Research and Education14
University of Sao Paulo13
University of Sao Paulo General Hospital12
Hospital Israelita Albert Einstein11
AstraZeneca7
Butantan Institute7
Pfizer7
BioNTech SE6
Azidus Brasil5
Fundação de Medicina Tropical Dr. Heitor Vieira Dourado5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
COVID-19306
Coronavirus Infections51
Severe Acute Respiratory Syndrome22
Pneumonia20
Respiratory Distress Syndrome11
Post-Acute COVID-19 Syndrome10
Respiratory Tract Infections8
Pneumonia, Viral7
Virus Diseases7
Anxiety Disorders6

Trials

Showing 1 to 25 of 306. Each trial links to its page on Pharma Observatory.

206 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.